Results 181 to 190 of about 34,933 (276)
Educational Case: Connective tissue disorders: Sjögren's syndrome. [PDF]
Patterson AS +2 more
europepmc +1 more source
Abstract Objectives To assess factors associated with rapidly progressive interstitial lung disease (ILD) (RP‐ILD) at time of ILD diagnosis in a multicentric retrospective cohort study of antisynthetase syndrome (ASyS). We used a complementary unsupervised approach, hierarchical clustering, to delineate distinct phenotypes among ASyS patients with ILD.
Maxime Billotte +16 more
wiley +1 more source
Meningoencephalitis as a presentation of primary Sjögren's syndrome: a case report. [PDF]
Karim AK +6 more
europepmc +1 more source
Objective Severalstudies have highlighted the role of Type I interferons (IFN‐I) in activating inflammatory pathways in lupus. However, no previous research focused on investigating the role of IFN‐I gene expression in the ophthalmologic involvement of systemic lupus erythematosus (SLE).
Raphael Teixeira Costa +6 more
wiley +1 more source
An Unusual Gastrointestinal Presentation of Sjogren's Syndrome: A Case Report. [PDF]
Sahwan O +5 more
europepmc +1 more source
Subcellular Redistribution and Surface Exposure of the Ro52, Ro60 and La48 Autoantigens During Apoptosis in Human Ductal Epithelial Cells: a Possible Mechanism in the Pathogenesis of Sjögren's Syndrome [PDF]
Maria Ohlsson +2 more
openalex +1 more source
Objective Multisystem inflammatory syndrome in children (MIS‐C) is a rare hyperinflammatory syndrome that follows SARS‐CoV‐2 infection. Prior plasma proteomic analysis from a 2020 cohort of patients with MIS‐C at our center revealed a profile characterized by thrombotic microangiopathy (TMA), macrophage activation syndrome (MAS)‐associated proteins ...
Sarah McCuaig +8 more
wiley +1 more source
Elevated IL-8 and abnormal lymphocytes in pediatric primary Sjögren's syndrome: a single-center study. [PDF]
Gao XF +11 more
europepmc +1 more source
Rheumatoid arthritis is a disease characterized by joint inflammation. Approximately 50% of patients show insufficient response to traditional synthetic disease‐modifying antirheumatic drugs. This study aims to elucidate differential molecular profiles of the mechanisms underlying drug responses through multi‐omics strategy.
Congcong Jian +26 more
wiley +1 more source

